Liu Z - Search Results

1

SU6668 suppresses proliferation of triple negative breast cancer cells through down-regulating MTDH expression.

Wang L, Liu Z, Ma D, Piao Y, Guo F, Han Y, Xie X. Wang L, et al. Among authors: liu z. Cancer Cell Int. 2013 Aug 29;13(1):88. doi: 10.1186/1475-2867-13-88. Cancer Cell Int. 2013. PMID: 23984913 Free PMC article.

2

Study on relationship between angiogenesis and micrometastases of peripheral blood in breast cancer.

Xie XD, Qu SX, Liu ZZ, Zhang F, Zheng ZD. Xie XD, et al. J Cancer Res Clin Oncol. 2009 Mar;135(3):413-9. doi: 10.1007/s00432-008-0473-4. Epub 2008 Sep 30. J Cancer Res Clin Oncol. 2009. PMID: 18825410

3

[Clinical observation of 21 cases of metastatic renal cell carcinoma treated with sorafenib].

Xie XD, Piao Y, Liu ZZ. Xie XD, et al. Zhonghua Zhong Liu Za Zhi. 2009 Sep;31(9):714-5. Zhonghua Zhong Liu Za Zhi. 2009. PMID: 20021872 Chinese. No abstract available.

4

Small breast epithelial mucin (SBEM) has the potential to be a marker for predicting hematogenous micrometastasis and response to neoadjuvant chemotherapy in breast cancer.

Liu ZZ, Xie XD, Qu SX, Zheng ZD, Wang YK. Liu ZZ, et al. Clin Exp Metastasis. 2010 Apr;27(4):251-9. doi: 10.1007/s10585-010-9323-2. Epub 2010 Apr 3. Clin Exp Metastasis. 2010. PMID: 20364301

5

EGF +61A>G polymorphism and gastrointestinal cancer risk: a HuGE review and meta-analysis.

Piao Y, Liu Z, Ding Z, Xu L, Guo F, Sun Q, Xie X. Piao Y, et al. Among authors: liu z. Gene. 2013 Apr 25;519(1):26-33. doi: 10.1016/j.gene.2013.01.057. Epub 2013 Feb 9. Gene. 2013. PMID: 23403233 Review.

6

Small breast epithelial mucin tumor tissue expression is associated with increased risk of recurrence and death in triple-negative breast cancer patients.

Liu L, Liu Z, Qu S, Zheng Z, Liu Y, Xie X, Song F. Liu L, et al. Among authors: liu z, liu y. Diagn Pathol. 2013 May 1;8:71. doi: 10.1186/1746-1596-8-71. Diagn Pathol. 2013. PMID: 23635316 Free PMC article.

7

[Autologous cytokine-induced killer cells therapy on the quality of life of patients with breast cancer after adjuvant chemotherapy: a prospective study].

Liang XF, Ma DC, Ding ZY, Liu ZZ, Guo F, Liu L, Yu HY, Han YL, Xie XD. Liang XF, et al. Zhonghua Zhong Liu Za Zhi. 2013 Oct;35(10):764-8. Zhonghua Zhong Liu Za Zhi. 2013. PMID: 24378099 Clinical Trial. Chinese.

8

[Preventive effect of low-dose carvedilol combined with candesartan on the cardiotoxicity of anthracycline drugs in the adjuvant chemotherapy of breast cancer].

Liu L, Liu ZZ, Liu YY, Zheng ZD, Liang XF, Han YL, Xie XD. Liu L, et al. Zhonghua Zhong Liu Za Zhi. 2013 Dec;35(12):936-40. Zhonghua Zhong Liu Za Zhi. 2013. PMID: 24506965 Clinical Trial. Chinese.

9

Prognostic function of Ki-67 for pathological complete response rate of neoadjuvant chemotherapy in triple-negative breast cancer.

Zhang G, Xie W, Liu Z, Lin C, Piao Y, Xu L, Guo F, Xie X. Zhang G, et al. Among authors: liu z. Tumori. 2014 Mar-Apr;100(2):136-42. doi: 10.1177/030089161410000204. Tumori. 2014. PMID: 24852856

10

Rosiglitazone amplifies the sensitivity of docetaxel and reduces the expression of CD44v6.

Ji F, Ma D, Liu Z, Xie X. Ji F, et al. Among authors: liu z. Oncol Lett. 2014 Apr;7(4):1284-1288. doi: 10.3892/ol.2014.1824. Epub 2014 Jan 24. Oncol Lett. 2014. PMID: 24944709 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

90,722 results

Search Page

Filters